Rapid Micro Biosystems, Inc. (RPID) Fair Value 2026

RPID · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.1 /10

32 fundamental signals · 2 models active

Value Trap Risk

LOW (39/100)

Quick Summary — As of 2026-08-28, Rapid Micro Biosystems, Inc. (RPID) trades at $1.57, versus a $0.87 median fair value across its 2 active models — 44.7% below the current price. QOC: 6.1/10. Value Trap Risk: 39/100 (LOW). 2/13 models active.

Key Facts

Ticker
RPID
Price
$1.57
Quality Score
6.1/10
Value Trap Risk
39/100
Models Active
2/13
Last Updated
Strength: 2 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Rapid Micro Biosystems, Inc. (RPID) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Rapid Micro Biosystems, Inc. (RPID) appears overvalued as of : the median of 2 independent fair value estimates is $0.87, 44.7% below the current price of $1.57. Estimates range from $0.86 to $0.87. RPID scores 6.1/10 on fundamental quality and 39/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. RPID’s -44.7% gap is wider than that market norm, and the Medical Devices sector median is -43.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Rapid Micro Biosystems, Inc. Stock in 2026? →

What Fair Value Does Each Model Give RPID?

2 Intrinsic Value Models vs. Current Price ($1.57)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.86 -45.0%
Option-Based · Medium Conviction
 $0.87 -44.4%

All Models Active

All 2 models are displayed above.

What Is Rapid Micro Biosystems, Inc. (RPID) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Rapid Micro Biosystems, Inc.'s intrinsic value is estimated at $0.87, suggesting the stock is overvalued at its current price of $1.57. With 2 out of 2 models flagging downside (-44.7% vs price), the market may be pricing in unsustainable growth.

What Do the Models Say About RPID?

2 of 13 models are currently active for RPID. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for RPID is $0.87 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does RPID Rank in Medical Devices?

Among 159 Medical Devices stocks, RPID ranks #89 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

Within the Medical Devices space, Rapid Micro Biosystems, Inc. competes in an environment where biosimilar competition timeline often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is RPID a Value Trap?

CirclFi's Value Trap algorithm assigns RPID a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Rapid Micro Biosystems, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Rapid Micro Biosystems, Inc. is rated at 6.1/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

Models cluster within a tight range (+0.6% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every RPID valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across RPID's 2 active models, average confidence is 41%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Rapid Micro Biosystems, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

ENOVEnovis CorporationQOC 6.1NMTCNeuroOne Medical Technologies CorporationQOC 6.1BBNXBeta Bionics, Inc.QOC 6.1AIDX20/20 Biolabs, Inc.QOC 6.0CBLLCeriBell, Inc.QOC 6.1VYCOVycor Medical, Inc.QOC 6.0MBOTMicrobot Medical Inc.QOC 4.9INSPInspire Medical Systems, Inc.QOC 9.0MASS908 Devices Inc.QOC 7.1IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: ENOV · NMTC · BBNX · AIDX · CBLL · VYCO · MBOT · INSP · MASS · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to RPID?

7 companies across all industries closest to RPID’s Quality of Company score of 6.1/10.

RANDRand Capital CorporationQOC 6.1SUGPSU Group Holdings LimitedQOC 6.1STXSStereotaxis, Inc.QOC 6.1IORIncome Opportunity Realty Investors, Inc.QOC 6.1BRCCBRC Inc.QOC 6.1VODVodafone Group Public Limited CompanyQOC 6.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: RAND · SUGP · STXS · IOR · BRCC · VOD · NVDA

Where Does RPID Sit in CirclFi's Medical Devices Rankings?

RPID is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Rapid Micro Biosystems, Inc.’s Valuation?

What is Rapid Micro Biosystems, Inc.'s intrinsic value in 2026?

CirclFi puts Rapid Micro Biosystems, Inc. (RPID)'s intrinsic value at $0.87 — the median of 2 independent model estimates as of 2026-08-28, ranging from $0.86 to $0.87. The Quality of Company score is 6.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is RPID overvalued or undervalued right now?

At $1.57, 0 of 2 active models suggest RPID may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $0.87, 44.7% below the current price of $1.57 — a consensus view that RPID is overvalued. The assessment depends on which methodology best fits Rapid Micro Biosystems, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 6.1 mean for RPID?

Rapid Micro Biosystems, Inc.'s QOC of 6.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on RPID?

CirclFi analyzes RPID with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is RPID a value trap in 2026?

Rapid Micro Biosystems, Inc.'s Value Trap score is 39/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Rapid Micro Biosystems, Inc. (RPID) has a median fair value of $0.87 — 44.7% below the current price of $1.57 — as of 2026-08-28.” Source: circlfi.com/stock/RPID/ · Methodology
Primary sources for this RPID valuation
  • Financial statements: Rapid Micro Biosystems, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001380106) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for RPID as of ; valuations recomputed .